Jennison Associates LLC Raises Stock Holdings in Huron Consulting Group Inc. (NASDAQ:HURN)

Jennison Associates LLC boosted its holdings in Huron Consulting Group Inc. (NASDAQ:HURN - Free Report) by 5.7% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 574,006 shares of the business services provider's stock after buying an additional 31,123 shares during the period. Jennison Associates LLC owned approximately 3.24% of Huron Consulting Group worth $62,394,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Vanguard Group Inc. raised its stake in shares of Huron Consulting Group by 1.3% during the 1st quarter. Vanguard Group Inc. now owns 2,073,879 shares of the business services provider's stock valued at $200,378,000 after purchasing an additional 25,905 shares during the period. Boston Partners boosted its position in shares of Huron Consulting Group by 36.6% in the first quarter. Boston Partners now owns 922,254 shares of the business services provider's stock valued at $88,994,000 after acquiring an additional 247,218 shares during the period. Principal Financial Group Inc. grew its stake in Huron Consulting Group by 4.7% during the third quarter. Principal Financial Group Inc. now owns 380,024 shares of the business services provider's stock valued at $41,308,000 after acquiring an additional 17,146 shares in the last quarter. Leeward Investments LLC MA increased its holdings in Huron Consulting Group by 5.6% during the 2nd quarter. Leeward Investments LLC MA now owns 222,630 shares of the business services provider's stock worth $21,929,000 after acquiring an additional 11,902 shares during the period. Finally, American Century Companies Inc. lifted its stake in Huron Consulting Group by 1.0% in the 2nd quarter. American Century Companies Inc. now owns 181,834 shares of the business services provider's stock worth $17,911,000 after purchasing an additional 1,837 shares in the last quarter. Institutional investors own 93.90% of the company's stock.

Huron Consulting Group Stock Up 0.2 %

Shares of NASDAQ:HURN opened at $120.56 on Thursday. The firm has a fifty day moving average of $111.91 and a 200 day moving average of $103.86. Huron Consulting Group Inc. has a 52-week low of $84.26 and a 52-week high of $131.06. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.61 and a current ratio of 1.61. The firm has a market capitalization of $2.14 billion, a PE ratio of 26.21 and a beta of 0.60.

Huron Consulting Group (NASDAQ:HURN - Get Free Report) last posted its quarterly earnings data on Tuesday, October 29th. The business services provider reported $1.68 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.57 by $0.11. The firm had revenue of $370.00 million during the quarter, compared to analysts' expectations of $377.63 million. Huron Consulting Group had a return on equity of 21.51% and a net margin of 5.80%. The company's revenue for the quarter was up 3.3% compared to the same quarter last year. During the same period in the prior year, the business earned $1.39 EPS. As a group, research analysts anticipate that Huron Consulting Group Inc. will post 6.1 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, Director H Eugene Lockhart sold 1,042 shares of the firm's stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $109.48, for a total transaction of $114,078.16. Following the transaction, the director now directly owns 29,882 shares of the company's stock, valued at approximately $3,271,481.36. This trade represents a 3.37 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director James H. Roth sold 2,000 shares of Huron Consulting Group stock in a transaction dated Wednesday, November 6th. The stock was sold at an average price of $128.42, for a total value of $256,840.00. Following the completion of the transaction, the director now owns 54,825 shares in the company, valued at approximately $7,040,626.50. This represents a 3.52 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 5,126 shares of company stock valued at $604,420. 2.02% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on the stock. StockNews.com upgraded shares of Huron Consulting Group from a "hold" rating to a "buy" rating in a research report on Thursday, October 31st. Barrington Research upped their target price on Huron Consulting Group from $137.00 to $142.00 and gave the stock an "outperform" rating in a research note on Monday, November 4th. Finally, Benchmark reiterated a "buy" rating and set a $140.00 price target on shares of Huron Consulting Group in a research report on Wednesday, October 30th. Five research analysts have rated the stock with a buy rating, According to MarketBeat, the stock currently has an average rating of "Buy" and an average target price of $133.00.

Huron Consulting Group Company Profile

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children's and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.